1. Khursheed, T, Ovseiko, P, Dyball, S, Nakashima, R, Gonzalez, AMA, Babini, A et al.. Coalition for Health and Gender Equity (CHANGE)-a protocol for a global cross-sectional survey of health and gender equity in rheumatology. Rheumatol Adv Pract. 2024;8 (2):rkae021. doi: 10.1093/rap/rkae021. PubMed PMID:38560641 PubMed Central PMC10980588.
  2. Penglong, T, Boontanvansom, A, Viboonjuntra, P, Siripaitoon, B. Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis. 2023;34 (7):432-438. doi: 10.1097/MBC.0000000000001247. PubMed PMID:37577878 .
  3. Allanore, Y, Khanna, D, Smith, V, Aringer, M, Hoffmann-Vold, AM, Kuwana, M et al.. Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease. Rheumatology (Oxford). 2024;63 (3):639-647. doi: 10.1093/rheumatology/kead280. PubMed PMID:37294870 PubMed Central PMC10907814.
  4. Intapiboon, P, Pinpathomrat, N, Juthong, S, Uea-Areewongsa, P, Ongarj, J, Siripaitoon, B et al.. Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report. Vaccines (Basel). 2023;11 (3):. doi: 10.3390/vaccines11030537. PubMed PMID:36992120 PubMed Central PMC10054473.
  5. Furie, RA, van Vollenhoven, RF, Kalunian, K, Navarra, S, Romero-Diaz, J, Werth, VP et al.. Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus. N Engl J Med. 2022;387 (10):894-904. doi: 10.1056/NEJMoa2118025. PubMed PMID:36069871 .
  6. Werth, VP, Furie, RA, Romero-Diaz, J, Navarra, S, Kalunian, K, van Vollenhoven, RF et al.. Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus. N Engl J Med. 2022;387 (4):321-331. doi: 10.1056/NEJMoa2118024. PubMed PMID:35939578 .
  7. Ytterberg, SR, Bhatt, DL, Mikuls, TR, Koch, GG, Fleischmann, R, Rivas, JL et al.. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med. 2022;386 (4):316-326. doi: 10.1056/NEJMoa2109927. PubMed PMID:35081280 .
  8. Intapiboon, P, Siripaitoon, B. Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease. Respir Med Case Rep. 2020;31 :101299. doi: 10.1016/j.rmcr.2020.101299. PubMed PMID:33294359 PubMed Central PMC7695884.
  9. Sae-Lim, O, Laobandit, I, Kitchanwit, P, Laichapis, M, Siripaitoon, B. Prevalence and associated factors of medication nonadherence among Thai patients with systemic lupus erythematosus. Lupus. 2021;30 (2):352-359. doi: 10.1177/0961203320973072. PubMed PMID:33176565 .
  10. Intapiboon, P, Siripaitoon, B. Thai Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Outcomes and Risk Factors for Mortality. J Clin Rheumatol. 2021;27 (8):e378-e384. doi: 10.1097/RHU.0000000000001456. PubMed PMID:32568951 .
  11. Juthong, S, Geater, AF, Dekumyoy, P, Hortiwakul, T, Siripaitoon, B, Aiewruengsurat, D et al.. Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand. Lupus. 2020;29 (6):539-546. doi: 10.1177/0961203320911091. PubMed PMID:32183590 .
  12. Distler, O, Highland, KB, Gahlemann, M, Azuma, A, Fischer, A, Mayes, MD et al.. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. N Engl J Med. 2019;380 (26):2518-2528. doi: 10.1056/NEJMoa1903076. PubMed PMID:31112379 .
  13. Louthrenoo, W, Nilganuwong, S, Nanagara, R, Siripaitoon, B, Collaud Basset, S. Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial. Clin Rheumatol. 2019;38 (9):2461-2471. doi: 10.1007/s10067-019-04587-1. PubMed PMID:31104217 .
  14. Chiowchanwisawakit, P, Katchamart, W, Osiri, M, Narongroeknawin, P, Chevaisrakul, P, Kitumnuaypong, T et al.. Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. J Clin Rheumatol. 2019;25 (1):9-15. doi: 10.1097/RHU.0000000000000741. PubMed PMID:29517554 .
  15. Narongroeknawin, P, Chevaisrakul, P, Kasitanon, N, Kitumnuaypong, T, Mahakkanukrauh, A, Siripaitoon, B et al.. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. Int J Rheum Dis. 2018;21 (1):170-178. doi: 10.1111/1756-185X.12937. PubMed PMID:28737837 .
  16. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  17. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  18. Siripaitoon, B, Lertwises, S, Uea-Areewongsa, P, Khwannimit, B. A study of Thai patients with systemic lupus erythematosus in the medical intensive care unit: epidemiology and predictors of mortality. Lupus. 2015;24 (1):98-106. doi: 10.1177/0961203314548884. PubMed PMID:25149601 .
  19. Kwankaew, J, Leelawattana, R, Saignam, A, Siripaitoon, B, Uea-Areewongsa, P, Juthong, S et al.. Apolipoprotein B as an independent predictor of arterial stiffness in systemic lupus erythematosus patients. Int J Rheum Dis. 2015;18 (4):447-51. doi: 10.1111/1756-185X.12384. PubMed PMID:24797872 .
  20. Osiri, M, Wongchinsri, J, Ukritchon, S, Hanvivadhanakul, P, Kasitanon, N, Siripaitoon, B et al.. Comprehensibility, reliability, validity, and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis. Arthritis Res Ther. 2009;11 (4):R129. doi: 10.1186/ar2796. PubMed PMID:19709443 PubMed Central PMC2745813.
  21. Siripaitoon, B, Osiri, M, Vongthavaravat, V, Akkasilpa, S, Deesomchok, U. The prevalence of dyslipoproteinemia in Thai patients with systemic lupus erythematosus. Lupus. 2004;13 (12):961-8. doi: 10.1191/0961203304lu1084xx. PubMed PMID:15645754 .
Search PubMed